General Information of the Compound
| Compound ID |
CP0036921
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
3-HYDROXYTYRAMINE HYDROCHLORIDE
Show/Hide
|
||||||||||||||||||
| Synonyms |
(3H)-Dopamine
1,2-Benzenediol, 4-(2-aminoethyl)-(9CI)
1,2-Benzenediol, 4-(2-aminoethyl)-, hydrochloride
1,2-Benzenediol, 4-(2-aminoethyl)-, labeled with tritium
153C5321-5FEE-4B0B-8925-F388F0EEEBD1
2-(3,4-dihydroxyphenyl)ethylamine
2-benzenediol
3,4-Dihydroxyphenethylamine hydrochloride
3,4-Dihydroxyphenylethylamine
3,4-dihydroxyphenethylamine
3-Hydroxtyramine
3-Hydroxytyramine
3-Hydroxytyramine Hydrobromide
3-Hydroxytyramine hydrochloride
4-(2-Aminoethyl)-1
4-(2-Aminoethyl)-1,2-benzenediol
4-(2-Aminoethyl)-1,2-bezenediol
4-(2-Aminoethyl)benzene-1,2-diol
4-(2-Aminoethyl)catechol
4-(2-Aminoethyl)pyrocatechol
4-(2-Aminoethyl)pyrocatechol hydrochloride
4-(2-aminoethyl)-pyrocatechol
A-(3,4-Dihydroxyphenyl)-b-aminoethane
ASL 279
Alpha-(3,4-Dihydroxyphenyl)-beta-aminoethane
Beta-(3,4-Dihydroxyphenyl)ethylamine hydrochloride
Dopamin
Dopamina
Dopamina [INN-Spanish]
Dopamine
Dopamine (INN)
Dopamine (USAN)(*hydrochloride*)
Dopamine [INN:BAN]
Dopaminum
Dopaminum [INN-Latin]
Dophamine
Hydroxytyramin
Hydroxytyramine
IP 498
Intropin
Intropin [*hydrochloride*]
KW-3-060
L-DOPAMINE
LDP
M-Hydroxytyramine hydrochloride
Medopa (TN)
Oxytyramine
Pyrocatechol, 4-(2-aminoethyl)-(8CI)
Pyrocatechol, 4-(2-aminoethyl)-, hydrochloride
Revimine
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C8H11NO2
|
||||||||||||||||||
| Molecular Weight |
153.181
|
||||||||||||||||||
| Canonical SMILES |
NCCc1ccc(O)c(O)c1
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C8H11NO2/c9-4-3-6-1-2-7(10)8(11)5-6/h1-2,5,10-11H,3-4,9H2
Show/Hide
|
||||||||||||||||||
| InChIKey |
VYFYYTLLBUKUHU-UHFFFAOYSA-N
|
||||||||||||||||||
| CAS |
50444-17-2
51-61-6
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
| DrugBank ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01494, Beta-2 adrenergic receptor
Protein ID: PT01195, D(1A) dopamine receptor
Cell-based Assay
Protein ID: PT01169, D(1B) dopamine receptor
Protein ID: PT01005, D(2) dopamine receptor
Cell-based Assay
Protein ID: PT00957, D(2) dopamine receptor
Cell-based Assay
Protein ID: PT00943, D(3) dopamine receptor
Cell-based Assay
Protein ID: PT01366, D(3) dopamine receptor
Cell-based Assay
Protein ID: PT01161, D(4) dopamine receptor
Cell-based Assay
Protein ID: PT02684, D(4) dopamine receptor
Protein ID: PT01843, Melatonin receptor type 1A
Protein ID: PT02174, Melatonin receptor type 1B
Protein ID: PT01065, Serine/threonine-protein kinase mTOR
Protein ID: PT00884, Sodium-dependent dopamine transporter
Protein ID: PT01026, Sodium-dependent noradrenaline transporter
Protein ID: PT00871, Sodium-dependent serotonin transporter
Protein ID: PT04368, Solute carrier family 22 member 2
Protein ID: PT04763, Trace amine-associated receptor 1
Clinical Information about the Compound